ClinConnect ClinConnect Logo
Search / Trial NCT06641401

Endoscopic FHL Transfer for Acute Achilles Tendon Rupture

Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · Oct 12, 2024

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Achilles Tendon, Rupture, Endoscopic, Flexor Hallucis Longus Transfer

ClinConnect Summary

This evaluation will be performed by examining the following parameters:

1. Patient satisfaction quantified with the Achilles tendon Total Rupture Score (ATRS). This is the primary outcome.
2. Complication rate
3. Ankle and Calf circumference compared to the contralateral healthy limb.
4. Passive and Active range of ankle motion compared to the contralateral healthy limb.
5. Hallux flexion force compared to the contralateral healthy limb.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Signed Consent Form
  • Acute Achilles Tendon Rupture (\<4 weeks)
  • Underwent operative treatment with Endoscopic Flexor Hallucis Longus transfer
  • More than 24 months postoperative follow-up
  • Patients operated after 2015
  • Exclusion Criteria:
  • Inability or Unwillingness to cooperate
  • Medically unfit for examination
  • Age less than 18 or more than 75 years
  • Non-operative Management or any other Surgical Management
  • Neglected Achilles Tendon Rupture (\>4 weeks)
  • Bilateral Achilles Tendon Rupture
  • Patients operated before 1.1.2015 or after 1.1.2023
  • Comorbidities interfering with the secondary outcomes (e.g. Venous insufficiency resulting in lower limb excessive edema interferes with ankle and calf circumference, rheumatoid arthritis and/or previous foot and ankle surgery interferes with active and passive range of motion of the ankle, etc)

About Aristotle University Of Thessaloniki

Aristotle University of Thessaloniki (AUTH) is a prestigious institution in Greece, renowned for its commitment to advancing knowledge and innovation in the field of clinical research. As a leading academic sponsor of clinical trials, AUTH leverages its extensive resources and expertise to conduct rigorous studies that contribute to the understanding of various medical conditions and the development of novel therapeutic interventions. The university fosters collaboration among multidisciplinary teams, ensuring adherence to the highest ethical standards and regulatory requirements while promoting scientific excellence and enhancing patient care.

Locations

Náousa, Central Macedonia, Greece

Patients applied

0 patients applied

Trial Officials

Michail Kotsapas, MD, MSc

Principal Investigator

General Hospital of Naousa, Department of Orthopedics

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported